Author: Arjun Aurora (India)
Co-authors: Kamlesh Khilnani, Ajay Aurora
Purpose
To evaluate and compare the changes in microcirculation in diabetic eyes between OCTA (both, SCP (superficial capillary plexus) & DCP (Deep Capillary Plexus) and FFA over one year and to correlate these with the progression of diabetic retinopathy.
Setting/Venue
A prospective, non-randomized, non-interventional study done in the outpatient department of regional referral center
Methods
Three groups of diabetics (30 patients in each group) were studied over 12 months with exams at 0, 6, and 12 months. Group 1 (diabetics with no diabetic retinopathy), group 2 diabetics with diabetic retinopathy but no diabetic macular edema (DME), group 3 diabetics with diabetic retinopathy (DR), and DME. All patients underwent detailed eye exam and A) FFA with Zeiss Visucam 524 at 0,6 and 12 months and B) OCT +OCTA with Zeiss Angioplex OCT (Carl Zeiss Meditec, Dublin, CA): SD-OCT macular cube scan, 3x3 OCTA scan. OCTA images of DCP were marked using IMAGE J software after setting the scale to 1024x1024 pixels in a 3x3 mm scan area. OCTA images of SCP were marked using in-built Zeiss Angiometric of Angioplex OCT. The FAZ on FFA was manually outlined using the in-built Visupac freehand measuring tool.
Results
A) FFA FAZ area: Group1: baseline 0.48+/- 0.11; 6 months 0.49+/- 0.12; 1 year 0.50+/- 0.12sq.mm . Group 2: baseline 0.56+/- 0.0; 6 months 0.57+/- 0.11, 12 months 0.58+/- 0.11sq.mm. Group 3: at baseline 0.63+/- 0.11, 6 months 0.64+/- 0.11, 12 months 0.65+/- 0.12sq.mm. FAZ values were significant on comparing group 1 and group 3, at all points. B) OCTA (SCP) FAZ area: Group 1: baseline 0.397+/- 0.044; 6 months 0.401+/- 0.044; 12 months 0.405+/- 0.045sq.mm. Group 2: baseline 0.373+/- 0.050sq.mm; 6 months 0.377+/- 0.51sq.mm; 12 months 0.381+/- 0.053sq.mm. Group 3: baseline 0.468+/- 0.063sq.mm; 6 months 0.474+/- 0.065sq.mm; 12 months 0.477+/- 0.066sq.mm. C) OCTA (DCP) FAZ area: Group 1: baseline 0.60+/- 0.07; 6 months, 0.60+/- 0.08; 12 months 0.61+/- 0.08 sq.mm. Group 2: baseline was 0.61+/- 0.07; 6 months 0.63+/- 0.08; 12 months 0.64+/- 0.08 sq.mm. Group 3: baseline 0.72+/- 0.11, 6 months 0.75+/- 0.12, 12 months 0.77+/- 0.13sq.mm. Significance was noted at baseline, 6 months, and 12 months, on comparing group 2 with group 3, and group 1 and group 3 for both SCP and DCP.
Conlusions
There was a significant increase in the FAZ area on FFA in all 3 groups at 12 months and the FAZ area was greater with more severe diabetic retinopathy (groups 2&3) at both 6 and 12 months. There was a progressive significant increase in the FAZ at SCP and DCP in all three groups at 6 and 12 months and the worsening was significant when group 3 was compared with 1 and 2.It is possible that with increasing disease and a corresponding increase in the FAZ, there comes a point when DME sets in. To understand this, one would need a longer follow-up, which is a limitation of this study.
Financial Disclosure
None
Comments
-